Increasing access to prescription opioid painkillers may reduce opioid overdose deaths in the United States, according to a Rutgers study.
AstraZeneca halts two PhIII hyperkalemia studies intended to spotlight Lokelma’s clinical value
AstraZeneca announced early Friday morning that it is stopping work on two late-stage trials designed to gather value-added evidence for Lokelma in hyperkalemia, a chronic